PRTN3

Myeloblastin · P24158 · PRTN3 on Sugi Atlas →

6,489 patent compounds predicted against PRTN3, 4,090 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Acetic Acid Acetic Acid (SCHEMBL1275199) 0.79 12/20
Sivelestat Sivelestat (SCHEMBL123221) 0.71 12/20
Sivelestat Sivelestat (SCHEMBL566914) 0.69 12/20
Sivelestat Sivelestat (SCHEMBL597819) 0.68 12/20
Sivelestat Sivelestat (SCHEMBL1499929) 0.68 12/20
SCHEMBL2740677 SCHEMBL2740677 0.43 6/20
SCHEMBL3272714 SCHEMBL3272714 0.49 4/20
Ethadione Ethadione (SCHEMBL35279) 0.55 3/20
SCHEMBL1973323 SCHEMBL1973323 0.53 3/20
SCHEMBL769767 SCHEMBL769767 0.51 3/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL3149437) 0.49 3/20
SCHEMBL3657617 SCHEMBL3657617 0.44 3/20
SCHEMBL3654752 SCHEMBL3654752 0.43 3/20
SCHEMBL3657615 SCHEMBL3657615 0.41 3/20
Trimethadione Trimethadione (SCHEMBL28882) 0.41 3/20
SCHEMBL2353877 SCHEMBL2353877 0.67 2/20
SCHEMBL2353879 SCHEMBL2353879 0.67 2/20
SCHEMBL2291128 SCHEMBL2291128 0.63 2/20
SCHEMBL2353547 SCHEMBL2353547 0.56 2/20
SCHEMBL1436662 SCHEMBL1436662 0.56 2/20

Clinical trials — most relevant to PRTN3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
Fever and Neutropenia in Pediatric Oncology Patients PHASE3WITHDRAWN
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers PHASE2COMPLETED
Biologic Correlative Taxotere/AC PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
The Classification and Cause of Leukodystrophies of Unknown Cause nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
The Nosology and Etiology of Leukodystrophies of Unknown Causes nanCOMPLETED
Clinical and Molecular Characterisation of Orofaciodigital Syndromes and Other Clinical Phenotypes Secondary to Mutations in the OFD1 Gene nanUNKNOWN
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Inflammatory Genomics in Human Carotid Artery Disease nanCOMPLETED
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia nanACTIVE_NOT_RECRUITING
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Linkage Study in Familial Pulmonary Fibrosis nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation nanRECRUITING
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Epidemiology of Gout in French Polynesia nanCOMPLETED
Pathophysiology of Paget's Disease of Bone nanCOMPLETED
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Genetic Basis of Abdominal Aortic Aneurysm nanCOMPLETED
French National Cohort of Patients With PRSS1 Mutations nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a PRTN3 binder may also engage these)

ProteinNameSimilarity
Q61096 0.990 Q61096 →
P79204 0.984 P79204 →
P21842 0.980 P21842 →
P56435 0.979 P56435 →
CMA1 Chymase 0.975 landscape →
Q7JIG6 0.974 Q7JIG6 →
P52195 0.974 P52195 →
P51124 0.973 P51124 →
CTSG Cathepsin G 0.972 landscape →
KLK14 Kallikrein-14 0.972 landscape →
Q9H2R5 0.972 Q9H2R5 →
KLK2 Kallikrein-2 0.971 landscape →
P20718 0.970 P20718 →
P17977 0.970 P17977 →
P50341 0.969 P50341 →
P28293 0.968 P28293 →
KLK3 Prostate-specific antigen 0.968 landscape →
Q6UWY2 0.967 Q6UWY2 →
O46683 0.967 O46683 →
Q6IE59 0.967 Q6IE59 →
A7WPL7 0.967 A7WPL7 →
Q14B24 0.966 Q14B24 →
Q07276 0.966 Q07276 →
P33619 0.966 P33619 →
Q03238 0.966 Q03238 →
KLK5 Kallikrein-5 0.966 landscape →
Q8CGR5 0.965 Q8CGR5 →
P19236 0.965 P19236 →
O43240 0.965 O43240 →
P80219 0.964 P80219 →